Skip to main content

Proscar News

FDA Warns of Unapproved Hair-Loss Product Linked to Side Effects

THURSDAY, April 24, 2025 — A quick spray of medication might seem like an easy way to get thicker hair, but some people say one sold online has left them battling sexual side effects, depression and e...

FDA Medwatch Alert: FDA Alerts Health Care Providers, Compounders and Consumers of Potential Risks Associated with Compounded Topical Finasteride Products

April 22, 2025 – FDA has become aware of reports of adverse events involving compounded topical finasteride products potentially putting consumers at risk. The agency is aware of some compounders...

FDA Medwatch Alert: 5-alpha reductase inhibitors (5-ARIs): Label Change - Increased Risk of Prostate Cancer

Drugs in the 5-ARI class include finasteride and dutasteride. These drugs are marketed under the brand-names Proscar, Propecia, Avodart, and Jalyn ISSUE: FDA notified healthcare professionals that...

FDA Medwatch Alert: Citalopram And Finasteride by Greenstone: Recall - Possible Mislabeling

ISSUE: Greenstone LLC announced a recall of medicines with lot number FI0510058-A on the label. Bottles labeled as Citalopram (used to treat depression) may contain Finasteride (used for the...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Benign Prostatic Hyperplasia (BPH)

Proscar patient information at Drugs.com